688089 logo

Cabio Biotech (Wuhan) Co., Ltd. Stock Price

SHSE:688089 Community·CN¥4.0b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

688089 Share Price Performance

CN¥23.68
-1.42 (-5.66%)
CN¥23.68
-1.42 (-5.66%)
Price CN¥23.68

688089 Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

2 Risks
4 Rewards

Cabio Biotech (Wuhan) Co., Ltd. Key Details

CN¥596.5m

Revenue

CN¥313.3m

Cost of Revenue

CN¥283.2m

Gross Profit

CN¥113.5m

Other Expenses

CN¥169.7m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
n/a
1.02
47.48%
28.45%
6.4%
View Full Analysis

About 688089

Founded
1999
Employees
574
CEO
Dewei Yi
WebsiteView website
www.cabio.cn

Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. Its products are used in infant formula food, health food, dietary supplements, and other fields for special medical purposes, pet nutrition food, economic animal feed, personal care and cosmetics, and other fields. The company was founded in 1999 and is based in Wuhan, the People’s Republic of China.

Recent 688089 News & Updates

Recent updates

No updates